Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Res. 2015 Jun 4;75(15):2999–3009. doi: 10.1158/0008-5472.CAN-15-0840

Figure 4. Glucose and glutamine flux to glutamate is reduced in U87 IDH1 mutant cells.

Figure 4

Schematic representation of 13C-labeling of glutamate and 2-HG derived from 1-13C-glucose and 3-13C-glutamine (A). Build-up of 3-13C-glutamate (3-13C-GLU) and 3-13C-2-HG following perfusion of U87IDHwt and U87IDHmut cells with 3-13C-glutamine (3-13C-GLN) with quantification of 3-13C-glutamate production shown in the inset (B). Build-up of 3-13C-lactate (3-13C-LAC), 4-13C-glutamate (4-13C-GLU) and a combined signal of 4-13C-glutamate and 4-13C-2-HG in U87IDHwt and U87IDHmut cells with quantification of the build-up of glutamate in right inset. Left inset illustrates data from cell extracts resolving 2-HG and glutamate (C).